查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1565721

臨床前 CRO 市場，按服務、按模型類型、按最終用途、按國家和地區分類：2024 年至 2032 年的行業分析、市場規模、市場佔有率和預測

Preclinical CRO Market, By Service, By Model Type, By End Uses, By Country, and By Region: Industry Analysis, Market Size, Market Share, and Forecast from 2024 to 2032
出版日期: | 出版商: AnalystView Market Insights | 英文 303 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

報告要點

2023 年臨床前 CRO 市場規模預估為 57.542 億美元，2024 年至 2032 年複合年成長率為 8.90%。

臨床前CRO市場-市場動態

透過外包服務臨床前 CRO 市場成長激增

對外包服務的需求不斷成長預計將推動臨床前 CRO 市場的未來成長。外包服務是與第三方提供者簽訂合約來處理特定業務任務或營運的做法。臨床前研究變得越來越複雜，需要專業技能和經驗，但並非所有製藥和生技公司都擁有內部技能和經驗。外包給臨床前 CRO 使企業能夠獲得所需的知識，而無需投資於能力開發，使他們能夠在進行臨床前研究的同時專注於核心業務。例如，根據美國獨立策略資訊和分析提供者BioPlan Associates Inc. 對207 名生物製藥受訪者和138 家供應商進行的調查，2023 年4 月，約84.6% 的生物製造商外包分析測試，74.5%外包毒性測試因此，對外包服務的需求不斷成長正在推動臨床前 CRO 市場的發展。

臨床前 CRO 市場 - 關鍵見解

我們的研究分析師預測 2024 年至 2032 年全球市場的複合年成長率為 8.90%。

根據服務細分研究，到 2023 年，毒理學測試類別將佔據全球臨床前 CRO 市場的最大收入佔有率。

2023 年，按模型類型細分，患者衍生類器官 (PDO) 模型領域在全球臨床前 CRO 市場中佔據主導地位。

按地區分類，北美地區 2023 年收入最高。

臨床前 CRO 市場細分分析：

全球臨床前 CRO 市場分為四組：服務、模型類型、最終用途和地理位置。

根據服務，市場分為六個部分：毒理學測試、生物分析和 DMPK 研究、化學、化合物管理、安全藥理學等。 2023年，由於非核心臨床前CRO研究外包的增加以及毒理學測試的廣泛使用，毒理學測試類別在全球臨床前CRO市場中佔據最高的收入佔有率。由於 CRO 進行毒理學測試的能力增強，毒理學是外包給 CRO 的主要服務之一。將非核心臨床前研究外包給 CRO 的比例不斷增加，以及 CRO 提供額外增值服務的能力不斷增強，可能會在預測期內推動這一類別的擴張。

根據模型類型，市場分為兩個部分：患者來源的類器官（PDO）模型和患者來源的異種移植模型。 2023 年，患者衍生類器官 (PDO) 模型細分市場佔有最大市場佔有率。由於利用直接源自患者的細胞和組織，患者來源的類器官（PDO）模型越來越受歡迎。這有助於個人化醫療保健，並且可以冷凍保存標本。由於這些原因，它們正在成為臨床前研究的一個重要方面，因為它們有助於更快地檢測和預後癌症。

臨床前 CRO 市場 - 地理洞察

市場地理多元化，遍及歐洲、中東、北美、亞太地區、非洲、拉丁美洲。這些地區被帶來商業的國家進一步分類。

北美地區在 2023 年的比例最高，因為存在專注於早期藥物發現的成熟 CRO，例如 Charles River Laboratories 和 LabCorp。美國是最大的臨床前試驗外包市場，一些生物製藥公司更願意將其臨床前試驗外包給位於美國的 CRO，以便從 FDA 批准的研究性新藥 (IND) 申請中受益。

同樣預期亞太地區在預測期內將以最快的速度成長。由於跨國公司外包業務模式的轉變和研發成本的上升，以及印度和中國等國家 CRO 提供的成本效率，亞太地區的臨床前外包預計將擴大。來自西歐和美國的老牌公司在亞太地區尋求分析服務、現場研究開發和臨床活動，以降低研究成本。

臨床前CRO市場-競爭格局：

臨床前合約研究組織 (CRO) 市場的競爭高度多元化，大型公司和新興企業都在其臨床前服務平台上運作。市場上的主要參與者包括 Eurofins Scientific、LABCOR、PRA Health Sciences, Inc. 等。科文斯擁有出色的臨床前產品組合服務範圍，並且在藥物開發方面擁有豐富的經驗。該領域的主要參與者包括藥明康德（WuXi AppTec）和PPD（PPD），前者提供所有藥物開發過程的整合解決方案，後者以其全球影響力和能力而聞名。規模較小的 CRO 也不斷湧現，它們針對自己擅長的特定治療領域，進一步推動了臨床前研究，加劇了競爭。

最新進展：

2023 年 3 月，Crown Bioscience 和 JSR 生命科學公司宣佈在新加坡開設新工廠，這將幫助該公司提高為本地和全球生物技術和製藥公司提供服務的能力。該網站將幫助參與臨床前和轉化腫瘤藥物研究和開發的公司。

目錄

第1章：臨床前 CRO 市場概述

  • 研究範圍
  • 市場預估年份

第 2 章：執行摘要

  • 市場片段
    • 按服務分類的臨床前 CRO 市場片段
    • 按模型類型分類的臨床前 CRO 市場片段
    • 按最終用途分類的臨床前 CRO 市場片段
    • 按國家/地區分類的臨床前 CRO 市場片段
    • 按地區分類的臨床前 CRO 市場片段
  • 競爭洞察

第 3 章：臨床前 CRO 主要市場趨勢

  • 臨床前 CRO 市場促進因素
    • 市場促進因素的影響分析
  • 臨床前CRO市場限制
    • 市場限制影響分析
  • 臨床前CRO市場機會
  • 臨床前CRO市場未來趨勢

第 4 章：臨床前 CRO 產業研究

  • PEST分析
  • 波特五力分析
  • 成長前景圖
  • 規範架構分析

第 5 章：臨床前 CRO 市場：COVID-19 影響分析

  • COVID-19 之前的影響分析
  • COVID-19 後影響分析
    • 表現最佳的市場區隔
    • 邊際成長市場區隔
    • 最寬鬆的市場區隔
    • 邊際損失市場區隔

第 6 章：臨床前 CRO 市場格局

  • 2023 年臨床前 CRO 市佔率分析
  • 按主要製造商分類的故障數據
    • 既有參與者分析
    • 新興參與者分析

第 7 章：臨床前 CRO 市場 - 按服務分類

  • 概述
    • 按服務分類的細分市場佔有率分析
    • 毒理學測試
    • 生物分析和 DMPK 研究
    • 化學
    • 化合物管理
    • 安全藥理學
    • 其他

第 8 章：臨床前 CRO 市場 - 按模型類型

  • 概述
    • 按車型類型分類的細分市場佔有率分析
    • 患者來源的類器官 (PDO) 模型
    • 患者來源的異種移植模型

第 9 章：臨床前 CRO 市場 - 按最終用途

  • 概述
    • 按最終用途分類的細分市場佔有率分析
    • 醫療器材公司
    • 生物製藥
    • 政府及學術機構

第 10 章：臨床前 CRO 市場 - 按地理位置

  • 介紹
    • 按地理位置分類的細分市場佔有率分析
  • 北美洲
    • 概述
    • 北美臨床前CRO主要生產商
    • 北美市場規模和預測（按國家）
    • 北美市場規模和預測（按服務）
    • 北美市場規模和預測（按車型類型）
    • 北美市場規模和預測（按最終用途）
    • 美國
    • 加拿大
  • 歐洲
    • 概述
    • 歐洲臨床前CRO主要製造商
    • 歐洲市場規模和預測（按國家）
    • 歐洲市場規模和預測（按服務）
    • 歐洲市場規模和預測（按車型類型）
    • 歐洲市場規模和預測（按最終用途）
    • 德國
    • 義大利
    • 英國
    • 法國
    • 俄羅斯
    • 荷蘭
    • 瑞典
    • 波蘭
    • 歐洲其他地區
  • 亞太地區 (APAC)
    • 概述
    • 亞太地區臨床前CRO主要製造商
    • 亞太地區市場規模與預測（按國家）
    • 亞太地區市場規模與預測（按服務）
    • 亞太地區市場規模和預測（按型號類型）
    • 亞太地區市場規模和預測（按最終用途）
    • 印度
    • 中國
    • 日本
    • 韓國
    • 澳洲
    • 泰國
    • 印尼
    • 菲律賓
    • 亞太地區其他地區
  • 拉丁美洲
    • 概述
    • 拉丁美洲臨床前CRO主要製造商
    • 拉丁美洲市場規模與預測（按國家）
    • 拉丁美洲市場規模與預測（按服務）
    • 拉丁美洲市場規模與預測（按車型類型）
    • 拉丁美洲市場規模和預測（按最終用途）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥倫比亞
    • 拉丁美洲其他地區
  • 中東和非洲
    • 概述
    • 中東和非洲臨床前CRO主要製造商
    • 中東和非洲市場規模及預測（按國家）
    • 中東和非洲市場規模及預測（按服務）
    • 中東和非洲市場規模及預測（按車型類型）
    • 中東和非洲市場規模和預測（按最終用途）
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 以色列
    • 土耳其
    • 阿爾及利亞
    • 埃及
    • MEA 的其餘部分

第 11 章：主要供應商分析 - 臨床前 CRO 產業

  • 競爭儀表板
  • 公司簡介
    • Eurofins Scientific
    • LABCORP
    • PRA Health Sciences, Inc.
    • Wuxi AppTec
    • Medpace, Inc.
    • PPD (Thermo Fisher Scientific, Inc.)
    • Charles River Laboratories International, Inc.
    • SGA SA
    • Intertek Group Plc (IGP)
    • Crown Bioscience
    • Others

第 12 章：360 度分析師視角

第 13 章：附錄

  • 研究方法
  • 參考
  • 縮寫
  • 免責聲明
  • 聯絡我們
簡介目錄
Product Code: ANV3904

REPORT HIGHLIGHT

Preclinical CRO Market size was evaluated at USD 5,754.2 million in 2023, rising at a CAGR of 8.90% between 2024 and 2032.

Preclinical CROs (contract research organizations) are support organizations that provide the knowledge in research and development required to guide a drug candidate through animal testing and into clinical trials. A preclinical CRO helps innovative medical product producers demonstrate safety and efficacy in animals that closely resemble human anatomy before entering clinical trials or being employed in human care.

Preclinical CRO Market- Market Dynamics

Surge In Preclinical CRO Market Growth Through Outsourcing Services

Growing demand for outsourcing services is projected to drive future growth in the preclinical CRO market. Outsourcing services is the practice of contracting with a third-party provider to handle specific business tasks or operations. Preclinical research is getting more sophisticated, necessitating specialized skills and experience that not all pharmaceutical and biotechnology companies possess in-house. Outsourcing to preclinical CROs enables businesses to gain access to the knowledge they require without investing in capability development, allowing them to focus on core business while still conducting preclinical research. For instance, according to a survey of 207 biopharma respondents and 138 suppliers conducted by BioPlan Associates Inc., a US-based provider of independent strategic information and analysis, approximately 84.6% of biomanufacturers outsource analytical testing and 74.5% outsource toxicity testing in April 2023. As a result, increasing demand for outsourcing services is propelling the preclinical CRO market forward.

Preclinical CRO Market- Key Insights

Our research analyst predicts an 8.90% CAGR for the global market from 2024 to 2032.

In 2023, In 2023, the toxicology testing category accounted for the biggest revenue share of the worldwide preclinical CRO market, according to Service segmentation research.

In 2023, the Patient Derived Organoid (PDO) model sector dominated the worldwide Preclinical CRO market by Model Type segmentation.

According to region, North America had the most revenue in 2023.

Preclinical CRO Market- Segmentation Analysis:

The global Preclinical CRO Market is divided into four groups: Service, Model Type, End Uses, and geography.

The market is segmented into six divisions based on the Service: Toxicology Testing, Bioanalysis & DMPK Studies, Chemistry, Compound Management, Safety Pharmacology, and Others. In 2023, the toxicology testing category had the highest revenue share of the worldwide preclinical CRO market, owing to increased outsourcing of noncore preclinical CRO studies and widespread utilization of toxicology tests. toxicology is one of the primary services being outsourced to CROs due to their enhanced ability to conduct toxicological tests. The increasing rate of outsourcing noncore preclinical investigations to CROs, as well as CROs' rising ability to provide additional value-added services, are likely to drive expansion in this category during the projection period.

The market is classified into two segments depending on the Model Type: The patient-Derived Organoid (PDO) Model and the Patient-derived xenograft model. In 2023, the Patient-Derived Organoid (PDO) Model segment had the most market share. The patient-derived organoid (PDO) model is gaining popularity due to the utilization of directly derived cells and tissues from the patient. This aids in individualized healthcare, and specimens can be cryopreserved. For these reasons, they are becoming an important aspect of preclinical investigations since they aid in the faster detection and prognosis of cancer.

Preclinical CRO Market- Geographical Insights

This market is geographically diversified across Europe, the Middle East, North America, Asia Pacific, and Africa, Latin America. The regions are further divided by the nations that bring commerce.

North America had the highest proportion in 2023 because to the presence of established CROs focusing in early drug discovery, such as Charles River Laboratories and LabCorp. The United States is the largest market for preclinical trial outsourcing, as several biopharmaceutical companies prefer to outsource their preclinical trials to CROs situated in the United States in order to benefit from FDA-approved Investigational New Drug (IND) applications.

Asia Pacific is likewise expected to increase at the quickest rate over the projection period. Preclinical outsourcing in Asia Pacific is predicted to expand because to the shifting business model of MNC outsourcing and rising R&D costs, as well as the cost efficiency offered by CROs in countries such as India and China. Established corporations from Western Europe and the United States pursue analytical services, site research development, and clinical activities in the Asia Pacific region to cut research costs.

Preclinical CRO Market- Competitive Landscape:

The Preclinical Contract Research Organization (CRO) Market is highly diversified concerning the competition, with both large companies and emerging players operating with their preclinical services platforms. The key profiled players in the market are Eurofins Scientific, LABCOR, PRA Health Sciences, Inc., and others. It features an excellent preclinical portfolio service range, and Covance boasts vast experience in drug development. Major players in this space include WuXi AppTec, which offers the integrated solutions of all the drugs' development process, and PPD, known for its global reach and capabilities. Smaller niche CROs are also emerging that target specific therapeutic areas where they have their specialties, further fueling preclinical research with a thus intensified competition.

Recent Developments:

In March 2023, Crown Bioscience and JSR Life Sciences Company have announced the opening of a new location in Singapore, which will help the company increase its capacity for local and worldwide biotech and pharmaceutical companies. The website will help companies involved in preclinical and translational oncology medication research and development.

SCOPE OF THE REPORT

This report's scope includes the following important market segments:

GLOBAL PRECLINICAL CRO MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • Eurofins Scientific
  • LABCORP
  • PRA Health Sciences, Inc.
  • Wuxi AppTec
  • Medpace, Inc.
  • PPD (Thermo Fisher Scientific, Inc.)
  • Charles River Laboratories International, Inc.
  • SGA SA
  • Intertek Group Plc (IGP)
  • Crown Bioscience
  • Others

GLOBAL PRECLINICAL CRO MARKET, BY SERVICE- MARKET ANALYSIS, 2019 - 2032

  • Toxicology Testing
  • Bioanalysis & DMPK Studies
  • Chemistry
  • Compound Management
  • Safety Pharmacology
  • Others

GLOBAL PRECLINICAL CRO MARKET, BY MODEL TYPE- MARKET ANALYSIS, 2019 - 2032

  • Patient-Derived Organoid (PDO) Model
  • Patient-derived xenograft model

GLOBAL PRECLINICAL CRO MARKET, BY END-USES- MARKET ANALYSIS, 2019 - 2032

  • Medical Device Companies
  • Biopharmaceutical
  • Government & Academic Institutes

GLOBAL PRECLINICAL CRO MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Preclinical CRO Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Preclinical CRO Market Snippet by Service
    • 2.1.2. Preclinical CRO Market Snippet by Model Type
    • 2.1.3. Preclinical CRO Market Snippet by End Uses
    • 2.1.4. Preclinical CRO Market Snippet by Country
    • 2.1.5. Preclinical CRO Market Snippet by Region
  • 2.2. Competitive Insights

3. Preclinical CRO Key Market Trends

  • 3.1. Preclinical CRO Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Preclinical CRO Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Preclinical CRO Market Opportunities
  • 3.4. Preclinical CRO Market Future Trends

4. Preclinical CRO Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Preclinical CRO Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Preclinical CRO Market Landscape

  • 6.1. Preclinical CRO Market Share Analysis, 2023
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Preclinical CRO Market - By Service

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Service, 2023 & 2032 (%)
    • 7.1.2. Toxicology Testing
    • 7.1.3. Bioanalysis & DMPK Studies
    • 7.1.4. Chemistry
    • 7.1.5. Compound Management
    • 7.1.6. Safety Pharmacology
    • 7.1.7. Others

8. Preclinical CRO Market - By Model Type

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Model Type, 2023 & 2032 (%)
    • 8.1.2. Patient-Derived Organoid (PDO) Model
    • 8.1.3. Patient-derived xenograft model

9. Preclinical CRO Market - By End Uses

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By End Uses, 2023 & 2032 (%)
    • 9.1.2. Medical Device Companies
    • 9.1.3. Biopharmaceutical
    • 9.1.4. Government & Academic Institutes

10. Preclinical CRO Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Preclinical CRO Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Service, 2019 - 2032 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Model Type, 2019 - 2032 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By End Uses, 2019 - 2032 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Service, 2019 - 2032 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Model Type, 2019 - 2032 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By End Uses, 2019 - 2032 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Service, 2019 - 2032 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Model Type, 2019 - 2032 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By End Uses, 2019 - 2032 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Preclinical CRO Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Service, 2019 - 2032 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Model Type, 2019 - 2032 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By End Uses, 2019 - 2032 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Service, 2019 - 2032 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Model Type, 2019 - 2032 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By End Uses, 2019 - 2032 (US$ Million)
    • 10.3.8. Italy
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.8.3. Italy Market Size and Forecast, By Service, 2019 - 2032 (US$ Million)
      • 10.3.8.4. Italy Market Size and Forecast, By Model Type, 2019 - 2032 (US$ Million)
      • 10.3.8.5. Italy Market Size and Forecast, By End Uses, 2019 - 2032 (US$ Million)
    • 10.3.9. United Kingdom
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.9.3. United Kingdom Market Size and Forecast, By Service, 2019 - 2032 (US$ Million)
      • 10.3.9.4. United Kingdom Market Size and Forecast, By Model Type, 2019 - 2032 (US$ Million)
      • 10.3.9.5. United Kingdom Market Size and Forecast, By End Uses, 2019 - 2032 (US$ Million)
    • 10.3.10. France
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.10.3. France Market Size and Forecast, By Service, 2019 - 2032 (US$ Million)
      • 10.3.10.4. France Market Size and Forecast, By Model Type, 2019 - 2032 (US$ Million)
      • 10.3.10.5. France Market Size and Forecast, By End Uses, 2019 - 2032 (US$ Million)
    • 10.3.11. Russia
      • 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.11.2. Russia Market Size and Forecast, By Service, 2019 - 2032 (US$ Million)
      • 10.3.11.3. Russia Market Size and Forecast, By Model Type, 2019 - 2032 (US$ Million)
      • 10.3.11.4. Russia Market Size and Forecast, By End Uses, 2019 - 2032 (US$ Million)
    • 10.3.12. Netherlands
      • 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.12.2. Netherlands Market Size and Forecast, By Service, 2019 - 2032 (US$ Million)
      • 10.3.12.3. Netherlands Market Size and Forecast, By Model Type, 2019 - 2032 (US$ Million)
      • 10.3.12.4. Netherlands Market Size and Forecast, By End Uses, 2019 - 2032 (US$ Million)
    • 10.3.13. Sweden
      • 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.13.2. Sweden Market Size and Forecast, By Service, 2019 - 2032 (US$ Million)
      • 10.3.13.3. Sweden Market Size and Forecast, By Model Type, 2019 - 2032 (US$ Million)
      • 10.3.13.4. Sweden Market Size and Forecast, By End Uses, 2019 - 2032 (US$ Million)
    • 10.3.14. Poland
      • 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.14.2. Poland Market Size and Forecast, By Service, 2019 - 2032 (US$ Million)
      • 10.3.14.3. Poland Market Size and Forecast, By Model Type, 2019 - 2032 (US$ Million)
      • 10.3.14.4. Poland Market Size and Forecast, By End Uses, 2019 - 2032 (US$ Million)
    • 10.3.15. Rest of Europe
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.15.3. Rest of the Europe Market Size and Forecast, By Service, 2019 - 2032 (US$ Million)
      • 10.3.15.4. Rest of the Europe Market Size and Forecast, By Model Type, 2019 - 2032 (US$ Million)
      • 10.3.15.5. Rest of the Europe Market Size and Forecast, By End Uses, 2019 - 2032 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Preclinical CRO Key Manufacturers in Asia Pacific
    • 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.4.4. Asia Pacific Market Size and Forecast, By Service, 2019 - 2032 (US$ Million)
    • 10.4.5. Asia Pacific Market Size and Forecast, By Model Type, 2019 - 2032 (US$ Million)
    • 10.4.6. Asia Pacific Market Size and Forecast, By End Uses, 2019 - 2032 (US$ Million)
    • 10.4.7. India
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.7.3. India Market Size and Forecast, By Service, 2019 - 2032 (US$ Million)
      • 10.4.7.4. India Market Size and Forecast, By Model Type, 2019 - 2032 (US$ Million)
      • 10.4.7.5. India Market Size and Forecast, By End Uses, 2019 - 2032 (US$ Million)
    • 10.4.8. China
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.8.3. China Market Size and Forecast, By Service, 2019 - 2032 (US$ Million)
      • 10.4.8.4. China Market Size and Forecast, By Model Type, 2019 - 2032 (US$ Million)
      • 10.4.8.5. China Market Size and Forecast, By End Uses, 2019 - 2032 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Service, 2019 - 2032 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Model Type, 2019 - 2032 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By End Uses, 2019 - 2032 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Service, 2019 - 2032 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Model Type, 2019 - 2032 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By End Uses, 2019 - 2032 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Service, 2019 - 2032 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Model Type, 2019 - 2032 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By End Uses, 2019 - 2032 (US$ Million)
    • 10.4.12. Thailand
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.12.3. Thailand Market Size and Forecast, By Service, 2019 - 2032 (US$ Million)
      • 10.4.12.4. Thailand Market Size and Forecast, By Model Type, 2019 - 2032 (US$ Million)
      • 10.4.12.5. Thailand Market Size and Forecast, By End Uses, 2019 - 2032 (US$ Million)
    • 10.4.13. Indonesia
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.13.3. Indonesia Market Size and Forecast, By Service, 2019 - 2032 (US$ Million)
      • 10.4.13.4. Indonesia Market Size and Forecast, By Model Type, 2019 - 2032 (US$ Million)
      • 10.4.13.5. Indonesia Market Size and Forecast, By End Uses, 2019 - 2032 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Service, 2019 - 2032 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Model Type, 2019 - 2032 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By End Uses, 2019 - 2032 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Service, 2019 - 2032 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Model Type, 2019 - 2032 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By End Uses, 2019 - 2032 (US$ Million)
  • 10.5. Latin America
    • 10.5.1. Overview
    • 10.5.2. Preclinical CRO Key Manufacturers in Latin America
    • 10.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.5.4. Latin America Market Size and Forecast, By Service, 2019 - 2032 (US$ Million)
    • 10.5.5. Latin America Market Size and Forecast, By Model Type, 2019 - 2032 (US$ Million)
    • 10.5.6. Latin America Market Size and Forecast, By End Uses, 2019 - 2032 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Service, 2019 - 2032 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Model Type, 2019 - 2032 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By End Uses, 2019 - 2032 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Service, 2019 - 2032 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Model Type, 2019 - 2032 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By End Uses, 2019 - 2032 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Service, 2019 - 2032 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Model Type, 2019 - 2032 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By End Uses, 2019 - 2032 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Service, 2019 - 2032 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Model Type, 2019 - 2032 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By End Uses, 2019 - 2032 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Service, 2019 - 2032 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Model Type, 2019 - 2032 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By End Uses, 2019 - 2032 (US$ Million)
  • 10.6. Middle East and Africa
    • 10.6.1. Overview
    • 10.6.2. Preclinical CRO Key Manufacturers in Middle East and Africa
    • 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.6.4. Middle East and Africa Market Size and Forecast, By Service, 2019 - 2032 (US$ Million)
    • 10.6.5. Middle East and Africa Market Size and Forecast, By Model Type, 2019 - 2032 (US$ Million)
    • 10.6.6. Middle East and Africa Market Size and Forecast, By End Uses, 2019 - 2032 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Service, 2019 - 2032 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Model Type, 2019 - 2032 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By End Uses, 2019 - 2032 (US$ Million)
    • 10.6.8. United Arab Emirates
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.8.3. United Arab Emirates Market Size and Forecast, By Service, 2019 - 2032 (US$ Million)
      • 10.6.8.4. United Arab Emirates Market Size and Forecast, By Model Type, 2019 - 2032 (US$ Million)
      • 10.6.8.5. United Arab Emirates Market Size and Forecast, By End Uses, 2019 - 2032 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Service, 2019 - 2032 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Model Type, 2019 - 2032 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By End Uses, 2019 - 2032 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Service, 2019 - 2032 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Model Type, 2019 - 2032 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By End Uses, 2019 - 2032 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Service, 2019 - 2032 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Model Type, 2019 - 2032 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By End Uses, 2019 - 2032 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Service, 2019 - 2032 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Model Type, 2019 - 2032 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By End Uses, 2019 - 2032 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Service, 2019 - 2032 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Model Type, 2019 - 2032 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By End Uses, 2019 - 2032 (US$ Million)

11. Key Vendor Analysis- Preclinical CRO Industry

  • 11.1. Competitive Dashboard
  • 11.2. Company Profiles
    • 11.2.1. Eurofins Scientific
    • 11.2.2. LABCORP
    • 11.2.3. PRA Health Sciences, Inc.
    • 11.2.4. Wuxi AppTec
    • 11.2.5. Medpace, Inc.
    • 11.2.6. PPD (Thermo Fisher Scientific, Inc.)
    • 11.2.7. Charles River Laboratories International, Inc.
    • 11.2.8. SGA SA
    • 11.2.9. Intertek Group Plc (IGP)
    • 11.2.10. Crown Bioscience
    • 11.2.11. Others

12. 360 Degree Analyst View

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us